Microbial enhancement for accelerated flowering in brassica napus
A novel microbial solution to accelerate flowering in Brassica napus using engineered bacteria that produce a flowering-controlling metabolite. This approach offers a faster alternative to traditional plant genetic modification and can be optimized with early-flowering plant varieties.
Overview
The proposed research introduces a cutting-edge microbial solution to accelerate the flowering time of Brassica napus by utilizing an engineered bacterial strain. This strain is designed to produce a metabolite known to influence flowering time, offering a more efficient alternative to conventional plant genetic modifications. By enhancing the natural flowering process, this technology could significantly benefit agricultural productivity and crop management.
Technical specifications
- Engineered Bacteria: The bacterial strain is engineered to produce and secrete a metabolite that promotes early flowering.
- Compatibility with Brassica napus: The approach is based on successful trials in Arabidopsis thaliana, and Brassica napus is a genetically similar plant.
- Optimization Potential: The solution can be combined with early-flowering plant varieties or mutants for enhanced results.
- Comprehensive Testing: Involves varying inoculation timing and dosage, alongside screening for strains that naturally produce the desired metabolite.
- Greenhouse Trials: Conducted to assess the impact on flowering time, biomass, and seed set under controlled conditions.
Technology readiness level
This microbial solution is currently at Technology Readiness Level 3, indicating that it has been experimentally proven in a laboratory setting with successful outcomes in related plants. Future greenhouse trials are planned to further validate its applicability to Brassica napus.
About University of Chicago
The University of Chicago is a private institution that brings together the power of 140 institutes and centers including an NCI-designated Comprehensive Cancer Center, a microbiome focused center, two U.S. Department of Energy National Labs (Argonne National Laboratory and Fermi National Accelerator Laboratory) and the Marine Biological Laboratory, making it a truly powerful research and development enterprise of over 15,000 faculty and research staff. UChicago is home to the Pritzker School of Molecular Engineering, launched in 2011 as the first and only engineering school in the U.S. focused entirely on molecular engineering with one of the major focused areas in immunoengineering, and a core partner of the Chan Zuckerberg (CZ) Biohub - Chicago. Researchers at UChicago have pioneered breakthroughs including discovering the link between cancer and genetics, establishing revolutionary theories of economics, and developing tools to enhance urban schooling. UChicago researchers are at the forefront of fields ranging from quantum computing, data science and artificial intelligence, to the modeling and synthesis of advanced materials, to oncology and neuroscience.
delivered to your inbox.